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Proteomics, Transcriptomics, Metabolomics, Cellomics, Lipidomics, 
Glycomics, Phamcogenomics, Neurogenetics and Nutrigenomics 
[13,14]. The output give us a better understanding of what metabolic 
syndromes are related to the development of disease pathogenesis in 
molecular levels such as obesity in which risk factors in network/cluster 
of molecules may interrupt by triggers (stressors) result from internal 
and external factors in various sources like environmental, genetic, 
and metabolic. Among them, neurogenetics and nutrigenomics are 
considered to describe which part of brain would modify stimulus to 
intake bad foods (poor nutrition) as energy resources or expenditure 
to resist or survival along with molecular networks in several organ 
interactions under brain circuits. Those omics approach may lead 
to provide solutions which brain circuit or interaction molecule 
network in the food and receptors on the tissue or organ while stress 
stimulate take food more as compensatory mechanism. To visualize 
an improved detection system in the tissue and monitoring brain 
reward cascade between brain and adipose tissue, better and earlier 
diagnostic tools such as Omics oriented strategy make a chance for 
success in treatment or provide personalized therapy for individuals.
Nutrigenomics is a study of the role of nutrients on how gene 
expression could be benefit to understand the cause of obesity and 
to determine underlying factors associated with various metabolic 
diseases due to molecular dysfunction in the mice and human body 
[15,16]. By using new technologies in the field of Omics, we can 
better visualize the molecular roadmap in metabolic diseases and 
gain better solutions by establishing a higher degree of dimensionality 
to understand the various deleterious effects of outside influences 
(treatment). Moreover, it gives us a better direction in risk management 
such as how food contamination from bacterial infection or food 
ingredients, chemical preservatives becomes oxidative stressors to 
defer impairment of homeostatic networks including the interruption 
of brain reward with specific dopaminergic receptor and abnormal 
metabolic cascade causing insulin resistance [17].
Oxidative stress occurs when cellular repair systems cannot 
readily detoxify ROS. Although ROS generation occurs during 
normal cellular metabolism within the mitochondria to generate 
energy, oxidative stress occurs when there is an imbalance of redox 
system which may lead to ROS-mediated toxicity linked damage 
with a variety of biological macromolecules includes lipid, DNA, 
and protein. Concordantly, ROS are key initiators of cellular 
signaling cascades that lead to various metabolic disorders such as 
Insulin Resistance (IR) and fasting hyperinsulinemia, which may 
be associated with mitochondrial dysfunction and oxidative stress 
[18]. Similar studies have indicated that the oxidative stress (i.e., 
ROS and RNS) produced by exogenous or endogenous factors 
influences complex dynamics of human behavior associated with 
health disparities like lack of vitamin D and exercise which should be 
of primary concern pertaining to endothelial dysfunction, systemic 
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Obesity (BMI > or = 30) rated as the second leading cause 
of death and an increasing socioeconomic burden such a public 
related aspects with a mortality rate that is likely 2.6 million people 
each year according to WHO. Obesity contributes to metabolic 
disorders causing imbalanced energy combined with genetic defects 
including the brain reward circuit and metabolic impairment [1-
4]. The prevalence of obesity may associate with environmental 
chemical exposure, which affects fat mass and adipogenesis in the 
United States [5]. However, it is poorly understood that the effects of 
several factors, for example, a wide range of stresses and medical over 
usage such as birth control pills, antidepressants, and antipsychotics 
reflects tissue damage and intervenes with the neuronal circuit due 
to evoked oxidative stress resulting from the interaction between 
macromolecules such as DNA, lipid and protein. Also including a 
wide range of environmental factors such as chemical ingredients 
found in a variety of foods and overburden stresses like the absence 
of smoking, pregnancy, menopause, sleeping disorder, anxiety, and 
respiratory problems which occur in everyday life. In addition, some 
reports indicate that obesity is associated with brain disorder like 
as malfunction of brain reward system against stimulatory impulse 
or responses. The mechanism underlying the molecular “trigger” 
for prevention and therapy in prominent metabolic disorder such 
as Obese and diabetes still remains to be a mystery. Interestingly, 
there are many evidences to support interaction between obesity and 
several types of disorders for example, dysglycemia, dyslipidemia, 
CVD, stroke, hypertension, and cancer including endometrial, 
breast, prostate, colon, and GI cancer [6-12]. Advent of Cutting edge 
knowledge derived from system biology and integration of genomics 
study such as GWAS and NGS- based detection tools can apply to 
diagnose and predict diseases status using clinic samples which 
may contain multilayer formulated macromolecules from patients. 
Both analytical tools could be optimized for precision of medicine 
for obesity and extended health complications and causes such as 
Cardiovascular Disorder (CVD) for atherogenic dyslipidemia and 
diabetes for insulin resistance on abdominal obesity as multiple 
metabolic risk factors. Prior to using genomics based analytical tools, 
analytic platform consist of several modules based on target molecules 
with various disciples of the study of Omics categories including 
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inflammation, and chronic hypertension by epigenetic and post-
translational modification [19-24]. Nutrigenomic and epigenetic 
studies are such a double-edged sword of discovery tool which 
generally focuses on dietary patterns according to genetic variations, 
the role of gene-nutrient interactions, gene-diet-phenotype 
interactions and epigenetic modifications caused by nutrients; these 
molecular tools will facilitate an understanding of the early molecular 
events that occur in diabetes and will contribute to the identification 
of better biomarkers and diagnostics tools. Omics approach could 
help to develop tailored diets that maximize the use of nutrients and 
cumulated functional ingredients present in good food, which should 
be treating aberrant adipose-like stem cell in the prevention Obese 
and delay of diabetes associated with other health complications.
In the future era, we consider that omics trial equipped with 
molecule based tools by stratification such as nutrigenomics, 
metabolomics, and neurogenetic research promises to discover a 
key knowledge of biological function which molecules may involve 
the pathogenesis network or compulsory individual response to 
diet pattern in alteration of brain circuit, which is also important to 
monitor environmental factors that interacts with molecule regulator 
such as microRNA in epigenetic area could lead to modulate disease 
risk [25-29]. A clear understanding of these interactions may drive 
to support the concept of disease prevention through stratification 
of risk pattern in personal medicine as well as optimization of 
dietary recommendations. Current research progress has been 
started to provide a resolution rapidly in the metabolic disorders 
including obesity, where specific targeted nutritional advice, such as a 
Mediterranean diet, helps to decrease cardiovascular risk factors and 
stroke incidence in people with polymorphisms strongly associated 
with type 2 diabetes. Omics is impacted to promote greater innovation, 
which encompass harness of stress from the environment to prevent 
metabolic disorders as well as improve quality of life with the health 
of food through different angles of approaches equipped with new 
detection modules such as protein array, NGS, metagenome, which 
will provide a framework for the development of genome-dependent 
food control for health brain reward strategies and the personalized 
approaches for the prevention and management of diabetes mellitus, 
stroke and CVD in public health.
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